Pre-treatment of the animals with FPR antagonists (Boc-MLF and WRW4) resulted in complete reversal of the effects of Cpd43, thus demonstrating the direct correlation between FPR activation by Cpd43 and reduction of arthritis severity. This evidence concerns the gene FPR1 and Arthritis.